More from Teva
 
MPR602-Teva-Neurologybytes-EHF-Article 7.2-V01-00-20190603.jpg

Migraine - Research

3 min

Can anti-CGRP monoclonal antibodies be beneficial for other painful conditions?

The neuropeptide calcitonin gene-related peptide (CGRP) plays a significant role in chronic neuropathic pain, and the therapeutic benefits of anti-CGRP monoclonal antibodies (mAbs) in migraine treatment are well established. However, CGRP is not only expressed in the central nervous system, but also in nearly all human organs.1 In a presentation at the 13th annual congress

Log in to read this article

If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.

LOG IN

Not Registered yet ? Register now